RGNT — REGENTIS BIOMATERIALS LTD.

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1912966 · Israel
Last close
$9.40
Market Cap
$48.69M
52W High
$15.50
52W Low
$1.23
ADV30
10,214,636
Next earnings
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 7,618,000 7,378,000 2,874,000
Jun 2025 475,000 189,000 44,807,000
Dec 2024 482,000 229,000 41,586,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-55,794,000
Inventory
Receivables
$230,000
ST Investments
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts
1

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -8,619,000 -13,648,000 7,618,000 2,874,000 -1,375,000
Dec 2024 0 932,000 4,801,000 482,000 41,586,000 -641,000
Dec 2023 0 -1,931,000 -4,132,000 360,000 46,265,000 -1,220,000
Dec 2022 0 -1,407,000 -1,449,000 1,717,000 43,778,000 -1,504,000
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
COCH Envoy Medical, Inc. $49.69M $0.65
STSS SkyAI, Inc. $47.40M $1.12
AURX Nuo Therapeutics, Inc. $50.35M $1.04
QTI QT IMAGING HOLDINGS, INC. $50.98M $3.85
MYO MYOMO, INC. $52.16M $1.35

News headlines (Yahoo Finance, 1h cache)

Why Did RGNT Stock Surge More Than 850% Today?
2026-06-15 18:06 · Yahoo
Regentis Biomaterials (RGNT) Advances European Commercial Launch Plans for GelrinC
2026-06-08 19:30 · Yahoo
Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
2026-06-08 12:32 · Yahoo
Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones
2026-06-01 19:15 · Yahoo
Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant
2026-05-29 19:15 · Yahoo
Regentis Biomaterials (RGNT) Is 'One to Watch'
2026-05-28 19:30 · Yahoo
Regentis Biomaterials (RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair
2026-05-26 19:40 · Yahoo
Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon
2026-04-16 12:30 · Yahoo
Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%
2026-03-17 12:30 · Yahoo
Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update
2026-02-24 21:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.